Yuling Qiu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
-
- Cardiac Ischemia and Reperfusion
- Cancer Mechanisms and Therapy
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 7
- Pharmacology 17
- Healthcare and Venom Research 7
- Berberine and alkaloids research 6
- Co-authors
- Dexin Kong (34 shared papers)Ran Wang (24 shared papers)Kailong Wang (5 shared papers)Shuangshuang Yin (14 shared papers)Haiyang Yu (10 shared papers)Tao Wang (6 shared papers)Xulei Tang (2 shared papers)Roberto Bolli (2 shared papers)
- Journals
- BioMed Research International (4 papers)Biomedicine & Pharmacotherapy (3 papers)Oncotarget (3 papers)Medicine (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Yuling Qiu
83 papers receiving 2.5k citations
Yuling Qiu's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 332
- Pathology and Forensic Medicine 379
- Developmental Neuroscience 72
- Pharmacology 294
- Pharmacology 155
Countries citing papers authored by Yuling Qiu
This map shows the geographic impact of Yuling Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Qiu more than expected).
Fields of papers citing papers by Yuling Qiu
This network shows the impact of papers produced by Yuling Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Qiu. The network helps show where Yuling Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuling Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anticancer activities of TCM and their active components against tumor metastasis Hit paper breakdown → | 2020 | 268 |
| 2 | 1995 | 204 | |
| 3 | 2020 | 187 | |
| 4 | 1998 | 148 | |
| 5 | 2019 | 139 | |
| 6 | 2016 | 136 | |
| 7 | 2016 | 129 | |
| 8 | 2017 | 75 | |
| 9 | 2012 | 71 | |
| 10 | 2014 | 50 | |
| 11 | 2021 | 45 | |
| 12 | 2015 | 40 | |
| 13 | 2018 | 39 | |
| 14 | 2016 | 39 | |
| 15 | 2011 | 34 | |
| 16 | 2018 | 34 | |
| 17 | 2019 | 33 | |
| 18 | 2018 | 33 | |
| 19 | 2012 | 31 | |
| 20 | 2021 | 29 |
About Yuling Qiu
Yuling Qiu is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Physiology and Oncology, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Venomous Animal Envenomation and Studies (8 papers), Insect and Pesticide Research (7 papers), Healthcare and Venom Research (7 papers), Hemoglobinopathies and Related Disorders (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Erythrocyte Function and Pathophysiology (6 papers), Autophagy in Disease and Therapy (6 papers) and Berberine and alkaloids research (6 papers). The work is most often cited by research in Cancer Research (332 citations), Pathology and Forensic Medicine (379 citations), Developmental Neuroscience (72 citations), Pharmacology (294 citations) and Pharmacology (155 citations). Yuling Qiu has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Dexin Kong, Ran Wang, Kailong Wang, Shuangshuang Yin, Haiyang Yu, Tao Wang, Xulei Tang, Roberto Bolli, Yiman Liu and Yingying Shao. Their work appears in journals such as BioMed Research International, Biomedicine & Pharmacotherapy, Oncotarget, Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.